Table S3.
Baseline characteristics of patients with and without NS5A RASs
| Characteristics | Wild type (n=36) | Mutation type (n=16) | P |
|---|---|---|---|
| Age (years), median (range) | 50 (18–70) | 42 (35–58) | 0.192 |
| Male (female) | 21 (15) | 7 (9) | >0.05 |
| Alb (g/L), median (range) | 44.35 (36.4–54.9) | 45.25 (24.6–48) | 0.513 |
| ALT (U/L), median (range) | 61 (10–189) | 66 (20–230) | 0.505 |
| AST (U/L), median (range) | 54 (14–163) | 47 (21–199) | 0.657 |
| γ-GGT (IU/L), median (range) | 57 (15–207) | 33 (9–97) | 0.054 |
| Total bilirubin (mg/dL), median (range) | 0.85 (0.44–1.91) | 0.63 (0.37–1.25) | 0.597 |
| Direct bilirubin (mg/dL), median (range) | 0.34 (0.22–0.79) | 0.33 (0.16–0.90) | 0.746 |
| Plt count (×109/L), median (range) | 153 (57–240) | 184 (56–315) | 0.323 |
| AST/Plt, median (range) | 0.43 (0.12–1.63) | 0.26 (0.1–1.80) | 0.867 |
| Hemoglobin (g/dL), median (range) | 153 (85–171) | 142.5 (77.4–178) | 0.907 |
| HCV RNA (log10 IU/mL), median (range) | 6.35 (3.00–7.5) | 6.57 (4.37–7.23) | 0.444 |
Abbreviations: HCV, hepatitis C virus; RASs, resistance-associated substitutions; Alb, albumin; Plt, platelet.